|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
���� |
|
ϸ������ |
| ��������������� | |
|
³������ |
|
����Ԫ��У |
| PubMed | |
|
Article by |
|
Article by |
�����ϸ�������о���չ
³������, ����Ԫ��У
�Ͼ�ҽ�ƴ�ѧ��һ����ҽԺƤ����
����ķ�������ϸ�������ơ�Ŀǰ�о���ʾ:�����ϸ������ѧ֤����Ҫ����������ѪCD4+ϸ���½�,��Ƥ��ֲ�����ȴ��CD8+Ϊ������һ������ܺ�CD8+ϸ����Ҫ������CD4+ϸ���Ȼ�ľ���;���й�;���Ǿֲ�CD8+ϸ����ijЩ�ֲ�ģʽ��ʾ����CD8+�ͺ���ϸ��֮���ֱ�����õĿ���;����,�йذ������װߵ��о��ཫΪ֮�ṩ������������
[2] 0rtonne JP.Alario A.T and B lymmphocytes in vitiligo.Arch Dermatol Res.1978.261(2):147-151.
[3] Mahmoud F,Abul H.al-Saleh Q,et al.Peripherar T-cell activation in non-segmental vitiligo.J Dematol,1998,25(10):637-640.
[4] Mozzanica N.Frigerio U,Finzi AF.et al.T cell subpopulations in vitili go:a chronobiologic study.J Am Acad Dermatol,1990,22(2 Pt 1):223-230.
[5] Grimes PE.Ghoneum M.Stockton T,et al.Z cell profiles in vitiligo.JAm Acad Dermatol,1986,14(2 Pt 1):196-201.
[6] Honda Y.Okubo Y,Koga M.Relationship between levels of soluble in-terleukin-2 receptors and the types and activity of vitiligo.J Dermatol,1997.24(9):561-563.
[7] Taher-Uz-Zaman.Begun S,Waheed MA.In vitro assessment of 'T'lymphocyte functioning in vitiligo.Support for autoimmune hypothesis concerning the disease.Acta Derm Venereol,1992,72(4):266-267.
[8] Hann SK.Park YK.Chung KY,et al.Peripheral blood lymphocyte im-balance in Koreans with active vitiligo.Int J Dermatol,1993,32(4):286-289.
[9] 0gg GS.Rod Dunbar P,Romero P,et al.High frequency of skin-homing melanocyte-specific cvtotoxic T lymphocytes in autoimmune vitiligo.J ExpMed.1998.188(6):1203-1208.
[10] Le Poole IC,van den Wijngaard RM,Westerhof W,et al.Presence of Tcells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance.Am J Pathol,1996,148(4):1219-1228.
[11] van den Wijngaard R,Wankowicz-Kalinska A,Le Poole C,et al.Localimmune response in skin of generalized vitiligo patients.Destruction ofmelanocytes is associated with the prominent presence of CLA + T cells atthe perilesional site.Lab Invest,2000,80(8):1299-1309.
[12] Le Poole IC,Mutis T.van den Wijngaard RM,et al.A novel,antigen-presenting function of melanoeytes and its possible relationship to hypopig-mentary disorders.J Immunol,1993,151 (12):7284-7292.
[13] Westerhof W,Groot I,Krieg SR,et al.Langerhans cell population studies with OKT6 and HLA-DR monoclonal antibodies in vitiligo patients treated with oral phenylalanine loading and UVA irradiation.Acta Derm Venereol,1986,66(3):259-262.
[14] Gilhar A.Aizen E,Ohana N,et al.Vitiliginous vs pigmented skin re-sponse to intradermal administration of interferon garma.Arch Dermatol,1993,129(5):600-604.
[15] Das PK,van den Wijngaard RM,Wankowicz-Kalinska A,et al.A symbi-otic concept of autoimmunity and tumour immunity:lessons from vitiligo.Trends Immunol,2001,22(3):130-136.
[16] Smyth JR Jr,McNeil M.Alopecia areata and universalis in the Smythchicken model for spontaneous autoimmune vitiligo.J Investig DermatolSymp Proc,1999,4(3):211-215.
[17] Abdel-Naser MB,Kruger-Krasagakes S,Krasagakis K,et al.Further evidence for involvement of both cell mediated and humoral immunity in generalized vitiligo.Pigment Cell Res,1994,7(1):1-8.
[18] Behrens-Wirliams SC,Peters EM,Schallreuter KU.In vivo delayed-typehypersensitivity in 109 patients with vitiligo.Int J Dermatol,2000,39(8):593-598.
[19] Zeff RA,Freitag A,Grin CM,et al.The immune response in halo nevi.J Am Acad Dermatol,1997,37(4):620-624.
[20] Akasu R,From L,Kahn HJ.Characterization of the mononuclear infil-trate involved in regression of halo nevi.J Cutan Pathol,1994,21 (4):302-311.
[21] Tokura Y,Yamanaka K,Wakita H,et al.Halo congenital nevus undergo-ing spontaneous regression.Involvement of T-cell immunity in involutionand presence of circulating anti-nevus cell IgM antibodies.Arch Dermatol,1994,130(8):1036-1041.
[22] Rosenberg SA,White DE.Vitiligo in patients with melanoma:normal tis-sue antigens can be targets for cancer immunotherapy.J Immunother Emphasis Tumor Immunol,1996,19(1):81-84.
[23] Nagai H,Hara I,Horikawa T,et al.Elimination of CD4(+) T cells en-hances anti-tumor effect of locally secreted interleukin-12 on B16 mouse melanoma and induces vitiligo-like coat color alteration.J Invest Dermatol,2000,115(6):1059-1064.
[24] Becker JC,Guldberg P,Zeuthen J,et al.Accumulation of identical Tcells in melanoma and vitiligo-like leukoderma.J Invest Dermatol,1999,113(6):1033-1038.
[25] Aubin F,Cahn JY,Ferrand C,et al.Extensive igo after ganciclovirtreatment of GvHD in a patient who had received donor T cells expressing herpes simplex virus thymidine kinase.Lancet,2000,355(9204):6226-762.